Medicare Enrolled

Dr. Ken Takesita, M.D.

Urology Physician · Riverside, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4500 BROCKTON AVE STE 301, Riverside, CA 92501
9512764505
In practice since 2008 (17 years)
NPI: 1629243837 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Takesita from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Takesita? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Takesita

Dr. Ken Takesita is an urology physician in Riverside, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Takesita performed 2,309 Medicare services across 1,506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Takesita received a total of $16,360 from 55 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Takesita is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 35% volume in CA $16,360 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,309
Medicare services
Top 35% in CA for urology physician
1,506
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~136 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
638 $69 $288
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
511 $9 $62
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
324 $95 $400
Leuprolide acetate (for depot suspension), 7.5 mg 129 $135 $438
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
107 $125 $257
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
96 $199 $564
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
88 $298 $1,214
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
88 $6 $248
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
88 $27 $313
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
52 $28 $53
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
42 $64 $117
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
35 $116 $507
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
25 $127 $228
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
22 $178 $396
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
22 $0 $4
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $88 $300
New patient office visit, complex (60-74 min) 21 $167 $323
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,360
Total received (2018-2024)
Avg $2,337/year across 7 years
Top 13% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,684 (65.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,676 (34.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$511
2023
$500
2022
$736
2021
$730
2020
$11,314
2019
$1,791
2018
$779

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$90
Janssen Biotech, Inc.
$69
IMMUNITYBIO, INC.
$54
Astellas Pharma US Inc
$50
PROCEPT BioRobotics Corporation
$39
Bayer Healthcare Pharmaceuticals Inc.
$31
Ferring Pharmaceuticals Inc.
$30
Axonics, Inc.
$30
Myriad Genetic Laboratories, Inc.
$27
Merck Sharp & Dohme LLC
$24
Becton, Dickinson and Company
$19
Sumitomo Pharma America, Inc.
$18
COLOPLAST CORP
$15
Antares Pharma, Inc.
$13
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$10,684
Astellas Pharma US Inc
$983
NeoTract Inc.
$769
Janssen Biotech, Inc.
$633
PFIZER INC.
$449
Bayer HealthCare Pharmaceuticals Inc.
$218
ABBVIE INC.
$168
Dendreon Pharmaceuticals LLC
$157
Endo Pharmaceuticals Inc.
$152
Hollister Incorporated
$152
Myriad Genetic Laboratories, Inc.
$147
Boston Scientific Corporation
$133
Axonics, Inc.
$123
Blue Earth Diagnostics Limited
$111
TOLMAR Pharmaceuticals, Inc.
$101
Coloplast Corp
$94
Rochester Medical Corporation
$83
Teleflex LLC
$70
Sumitomo Pharma America, Inc.
$69
Myovant Sciences Inc.
$64
Laborie Medical Technologies Corp.
$61
Allergan, Inc.
$61
Medtronic USA, Inc.
$59
IMMUNITYBIO, INC.
$54
Allergan Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
DENTSPLY IH Inc.
$44
Merck Sharp & Dohme Corporation
$41
AbbVie, Inc.
$41
PROCEPT BioRobotics Corporation
$39
AbbVie Inc.
$39
Agiliti Surgical, Inc.
$36
Antares Pharma, Inc.
$33
Ferring Pharmaceuticals Inc.
$30
Merck Sharp & Dohme LLC
$24
Photocure Inc
$23
Innovation Technologies Inc
$23
AngioDynamics, Inc.
$23
UroGen Pharma, Inc.
$22
SRS Medical Systems, Inc.
$22
180 Medical, Inc.
$22
Tolmar, Inc.
$21
Becton, Dickinson and Company
$19
Telix Pharmaceuticals
$18
Mission Pharmacal Company
$17
Supernus Pharmaceuticals, Inc.
$16
Avadel Specialty Pharmaceuticals, LLC
$15
COLOPLAST CORP
$15
PALETTE LIFE SCIENCES, INC.
$15
Sagent Pharmaceuticals, Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Accord Healthcare, Inc.
$14
ConvaTec Inc.
$13
UROVANT SCIENCES INC
$12
Egalet US Inc
$11
Top 3 companies account for 76.0% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENTLECATH · GREENLIGHT · Glydo · ILLUCCIX · INTERSTIM · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYRICA · LoFric · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · REZUM · SOLESTA · SPEEDICATH · SPRIX · SUTENT · SpeediCath · Surgical Camera Heads · TLANDO · TOVIAZ · ULTRASOUND PROBE · UROLIFT · UroCuff · UroLift · UroLift System · Urocit-K · VAPRO · VaPro · VaPro Plus Pocket · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for an urology physician in Riverside?
Compare urology physicians in the Riverside area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
80
Per 100K population
3.3
County median income
$89,672
Nearest hospital
RIVERSIDE COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Takesita is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 13% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Takesita experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Takesita performed 638 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Takesita receive payments from pharmaceutical companies?
Yes. Dr. Takesita received a total of $16,360 from 55 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Takesita's costs compare to other urology physicians in Riverside?
Dr. Takesita's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Takesita) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →